Tg Therapeutics reported $-66872000 in Operating Profit for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Abbvie ABBV:US $ 4717M 357M
Amgen AMGN:US $ 2500M 196M
Ardelyx ARDX:US $ -27.81M 7.47M
Arrowhead Research ARWR:US $ 41.55M 104.87M
Bayer BAYN:GR 4.21B 2.19B
Biogen BIIB:US $ 610.7M 23.6M
Corcept Therapeutics CORT:US $ 26.77M 9.9M
Curis CRIS:US $ -15.13M 2.57M
Dynavax Technologies DVAX:US $ 30.76M 49.95M
Gilead Sciences GILD:US $ 197M 743M
Infinity Pharmaceuticals INFI:US $ -12.41M 0.91M
Intercept Pharmaceuticals ICPT:US $ -10.27M 10.59M
Johnson & Johnson JNJ:US $ 5862M 1026M
Karyopharm Therapeutics KPTI:US $ -34586000 81.55M
Novartis NOVN:VX 2.85B 290M
Novavax NVAX:US $ 209.29M 1034.26M
Ptc Therapeutics PTCT:US $ -86.52M 1.79M
Puma Biotechnology PBYI:US $ -0.76M 7.79M
Regeneron Pharmaceuticals REGN:US $ 1258.5M 1381.2M
Spectrum Pharmaceuticals SPPI:US $ -14.06M 22.79M
Tg Therapeutics TGTX:US $ -66.87M 26.08M
Verastem VSTM:US $ -16.98M 0.47M
Vertex Pharmaceuticals VRTX:US $ 1040.9M 163.18M
Ziopharm Oncology ZIOP:US $ -9085000 1.97M